Concepedia

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

CH Polman, Ludwig Kappos, Mark S. Freedman, Gilles Edan, H-P Hartung, David H. Miller, Xavier Montalbán, Frederik Barkhof, Krzysztof Selmaj, Bernard M.J. Uitdehaag,

Journal of Neurology · 2007 · 75 citations · 23 references

DOIFull text

Open access

Concepts

References

23

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

Charles M. Poser, Donald W. Paty, Labe C. Scheinberg et al. · Annals of Neurology · 1983 · 7.4K citations

, , +12

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

, , +14

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

D. W. Paty, D.K.B. Li · Neurology · 1993 · 2K citations · Full text

, , +14

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

Roy W. Beck, Jack H. Simon, R. Phillip Kinkel et al. · New England Journal of Medicine · 2000 · 1.5K citations · Full text

, , +10

A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis

Roy W. Beck, Patricia A. Cleary, Malcolm M. Anderson et al. · New England Journal of Medicine · 1992 · 1.3K citations · Full text

, , +17